91
9.3. Atherosclerotic Disease
COR LOE
Recommendations
1 C-LD 1. In patients with aortic atherosclerotic disease and
concomitant coronary artery disease, PAD or both, it is
recommended to prescribe antiplatelet therapy, anticoagulant
therapy or both, guided by the clinical setting.
2a C-LD 2. In patients with aortic atherosclerotic disease and risk factors for
confirmed coronary artery disease, it is reasonable to prescribe a
moderate- or high-intensity statin.
2b C-LD 3. In patients with aortic atheromas of a thickness ≥4 mm, statin
therapy may be reasonable.
9.4.1. Coarctation of the Aorta
COR LOE
Recommendations
1 B-NR 1. In patients with CoA, including those who have undergone
surgical or endovascular intervention, an MRI or CT is
recommended for initial, surveillance, and follow-up aortic
imaging.
1 C-EO 2. In patients with CoA, BPs should be measured in both arms
and one of the lower extremities.
1 B-NR 3. In patients with significant native or recurrent CoA (Table
37) and hypertension, endovascular stenting or open surgical
repair of the coarctation is recommended.
1 C-EO 4. In patients with CoA, guideline-directed medical therapy is
recommended for the treatment of hypertension.
2b B-NR 5. In adult patients with CoA, screening for intracranial
aneurysms by MRI or CT may be reasonable.
